Nifty slipped for a third session as auto and energy stocks dragged. Analysts see a sluggish, range-bound trend between 26,000–26,300, with key breakout or breakdown levels guiding near-term direction and short-term trading strategies ahead.Read More

Angel One’s board will meet on January 15 to consider a stock split and its first interim dividend for FY26, alongside Q3 earnings, amid weak stock performance despite strong recent quarterly profit growth.Read More

Shares of billionaire Michael Saylor’s Strategy rose in premarket ‍trading on Wednesday, after ​MSCI dropped a plan to exclude the bitcoin hoarder and ⁠other crypto treasury firms from its indexes.Read More

Gold prices fell over 1% on Wednesday as investors booked profits after a recent rally, though it pared some losses after weaker-than-expected U.S. private payroll growth for December ‌bolstered bets on ‌Federal Reserve rate cuts.Read More

GameStop on Wednesday unveiled a compensation package worth roughly $35 billion ‍for CEO Ryan Cohen, hinging on a ​turnaround that requires him to lift the struggling videogame retailer’s market value ⁠more than tenfold and sharply boost its profit.Read More

Indian equities declined for a third session as heavyweight selling, geopolitical tensions and weak global cues dented sentiment. Analysts expect a cautious, range-bound market ahead of Q3 earnings and key US data, advising selective buying in defensives and large-cap themes.Read More

Rupee strengthened against the dollar despite equity outflows as RBI intervened aggressively to curb speculation. Central bank dollar sales lifted the currency to a three-week high, made it Asia’s top performer, and signalled tolerance for only limited one-sided moves ahead.Read More

U.S. online holiday spending growth slowed in the ‍2025 season, Adobe Analytics ​data showed on Wednesday, even as shoppers ⁠set a record on the back of steep discounts and wider use of buy-now-pay-later plans.Read More

U.S. ​crude stocks fell while gasoline and distillate ⁠inventories rose last week, the Energy Information Administration said on Wednesday.Read More

Microcap Mangalam Drugs saw multiple bulk deals as Vijay Kedia’s firm sold shares, yet the stock rose five percent. Despite a month-long rally, the stock remains deeply down year-on-year and trades below key moving averages after prolonged price erosion phase.Read More